Specialty Pharmacy

Drugs that treat autoimmune disorders and hepatitis C virus power specialty drug spending.

Lebrikizumab is a monoclonal antibody designed to treat atopic dermatitis.

T cell responses in different tumor models are fundamentally similar.

Changes include additional trial data in virologically-suppressed adults with HIV-1 infection.

Brandon Shank, PharmD, MPH, BCOP, discusses how pharmacists work with patients undergoing chemotherapy through transitions of care.

It may be possible to retrain the immune system to prevent or slow attacks on insulin-producing beta cells.

Baby boomer hepatitis C virus screening rates spiked when a prompt in their electronic health records reminded a primary care provider to recommend testing.

Patients who have received a transplant and are non-adherent to their medication regimens are more likely to experience graft failure and higher health care costs.

Marc O’Connor, chief operating officer at Curant Health, explains why treating the whole patient rather than just their specific disease is so important.

Hibernating innate lymphoid cells allows inflammation to persist in rheumatoid arthritis.

Top news of the day from across the health care landscape.

Understudied gene provides insight into how liver cancer cells gain the nutrition necessary to proliferate.

Younger patients with HIV have competing needs that distract them from fully engaging in care.

Legislative investigation seeks information from 7 drug makers on costs for MS medications.

Novel diabetes biosimilar shows similar safety, efficacy, and immunogenicity to the reference drug.

Brentuximab vedotin under evaluation for the treatment of cutaneous T-cell lymphoma.

The novel strategy could be more effective and less toxic than current chemotherapy drugs treating alternative lengthening telomere cancers.

Incentives for newly covered low-income patients may also reduce long-term costs.

Top news of the day from across the health care landscape.

Prolonged delay in antiretroviral treatment among patients necessitate scrutinization of the current guidelines for HIV therapy.

Pharmacy service was launched 6 years ago to help patients remain adherent to treatment regimens.

Carolyn Choate journeys 300 miles in a kayak to honor the pharmacologist who created the lifesaving aromatase inhibitor.

Top news of the week from Specialty Pharmacy Times.

Managing chronic pain after a cancer diagnosis remains a challenge.

The new compounds may lead to a highly effective, next-line treatment for estrogen receptor-positive breast cancer.

Hepatitis C elimination program screens more than 45K individuals in first 2 years of launch.

Top news of the day from across the health care landscape.

A gut microbe may play a role in the treatment of multiple sclerosis in the future.